A detailed history of Equitable Holdings, Inc. transactions in Vericel Corp stock. As of the latest transaction made, Equitable Holdings, Inc. holds 13,921 shares of VCEL stock, worth $604,171. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,921
Holding current value
$604,171
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$44.5 - $61.8 $619,484 - $860,317
13,921 New
13,921 $621,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.05B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Equitable Holdings, Inc. Portfolio

Follow Equitable Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Equitable Holdings, Inc. with notifications on news.